---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-037384"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:05:25.500236+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks shareholders approve reverse split; board sets 1:40 ratio

## Summary
- Reverse stock split approved by shareholders (4.7B votes for); board set ratio at 1:40.
- Split effective Aug 19; shares trade split-adjusted Aug 20 under symbol DNA.
- Every 40 shares of Common Stock combined into 1; fractional shares paid in cash.
- Warrants adjusted: exercise price $460/share (or $11.50 per warrant); 40 warrants per share.

## SEC filing metadata
- accession: 0001628280-24-037384
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828024037384/0001628280-24-037384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828024037384/dna-20240814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-037384
- JSON: https://secwatch.observer/filing/0001628280-24-037384.json
- Plain text: https://secwatch.observer/filing/0001628280-24-037384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.